Sight Sciences (SGHT) News Today $2.69 -0.38 (-12.38%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$2.69 0.00 (0.00%) As of 03/25/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8thMarch 25 at 4:05 PM | globenewswire.comBrokerages Set Sight Sciences, Inc. (NASDAQ:SGHT) Price Target at $3.83March 19, 2025 | americanbankingnews.comSight Sciences, Inc. (NASDAQ:SGHT) Receives Average Recommendation of "Hold" from AnalystsShares of Sight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) have been given a consensus rating of "Hold" by the seven research firms that are covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and two have given a buy recommendatiMarch 16, 2025 | marketbeat.comInsider Buying: Sight Sciences, Inc. (NASDAQ:SGHT) EVP Purchases 10,000 Shares of StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) EVP Manohar K. Raheja bought 10,000 shares of the firm's stock in a transaction that occurred on Wednesday, March 12th. The stock was acquired at an average price of $2.73 per share, for a total transaction of $27,300.00. Following the transaction, the executive vice president now owns 145,000 shares in the company, valued at $395,850. This trade represents a 7.41 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.March 14, 2025 | marketbeat.comManohar K. Raheja Acquires 10,000 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) StockMarch 14, 2025 | insidertrades.comSight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 GuidanceMarch 7, 2025 | nasdaq.comLake Street Capital Lowers Sight Sciences (NASDAQ:SGHT) Price Target to $2.50Lake Street Capital reduced their target price on shares of Sight Sciences from $3.00 to $2.50 and set a "hold" rating on the stock in a report on Thursday.March 7, 2025 | marketbeat.comSight Sciences (NASDAQ:SGHT) Given New $4.00 Price Target at Stifel NicolausStifel Nicolaus reduced their target price on shares of Sight Sciences from $5.00 to $4.00 and set a "buy" rating on the stock in a report on Thursday.March 7, 2025 | marketbeat.comPiper Sandler Lowers Sight Sciences (NASDAQ:SGHT) Price Target to $3.50Piper Sandler reduced their target price on shares of Sight Sciences from $5.50 to $3.50 and set a "neutral" rating on the stock in a research note on Thursday.March 7, 2025 | marketbeat.comSight Sciences (NASDAQ:SGHT) Receives "Hold" Rating from Needham & Company LLCNeedham & Company LLC restated a "hold" rating on shares of Sight Sciences in a report on Thursday.March 7, 2025 | marketbeat.comSight Sciences (NASDAQ:SGHT) Announces Quarterly Earnings ResultsSight Sciences (NASDAQ:SGHT - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.23) EPS for the quarter, missing the consensus estimate of ($0.22) by ($0.01). Sight Sciences had a negative net margin of 63.30% and a negative return on equity of 47.28%.March 6, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Q4 2024 Earnings Call TranscriptMarch 6, 2025 | msn.comSight Sciences price target lowered to $3.50 from $5.50 at Piper SandlerMarch 6, 2025 | markets.businessinsider.comSight Sciences (SGHT) Receives a Hold from Piper SandlerMarch 6, 2025 | markets.businessinsider.comSight Sciences Reports 2024 Results and 2025 OutlookMarch 5, 2025 | tipranks.comSight Sciences, Inc. (SGHT) Q4 2024 Earnings Conference Call TranscriptMarch 5, 2025 | seekingalpha.comSight Sciences sees FY25 revenue $70M-$75M, consensus $78.07MMarch 5, 2025 | markets.businessinsider.comSight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial GuidanceMarch 5, 2025 | globenewswire.comCitigroup Lowers Sight Sciences (NASDAQ:SGHT) Price Target to $3.00Citigroup decreased their price objective on shares of Sight Sciences from $4.60 to $3.00 and set a "neutral" rating for the company in a research note on Tuesday.March 5, 2025 | marketbeat.comSight Sciences Inc SGHTMarch 4, 2025 | morningstar.comCiti Reaffirms Their Hold Rating on Sight Sciences (SGHT)March 1, 2025 | markets.businessinsider.comSight Sciences (SGHT) to Release Earnings on WednesdaySight Sciences (NASDAQ:SGHT) will be releasing earnings after the market closes on Wednesday, March 5, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=637032)February 26, 2025 | marketbeat.comSight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual MeetingFebruary 24, 2025 | globenewswire.comSight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025February 19, 2025 | globenewswire.comSight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of "Hold" from AnalystsSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) has been given a consensus rating of "Hold" by the seven research firms that are currently covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and two have issued a buy recommenFebruary 19, 2025 | marketbeat.comSight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access DayFebruary 13, 2025 | finance.yahoo.comSight Sciences to Present at Citi's 2025 Unplugged MedTech and Life Sciences Access DayFebruary 13, 2025 | globenewswire.comSight Sciences stock hits 52-week low at $2.54 amid market challengesFebruary 13, 2025 | msn.comStifel Nicolaus Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock PriceStifel Nicolaus dropped their target price on shares of Sight Sciences from $6.00 to $5.00 and set a "buy" rating on the stock in a research note on Thursday.February 6, 2025 | marketbeat.comSight Sciences executives receive salary increases and bonus targetsJanuary 29, 2025 | msn.comUBS Group Lowers Sight Sciences (NASDAQ:SGHT) Price Target to $5.00UBS Group lowered their price objective on shares of Sight Sciences from $5.50 to $5.00 and set a "buy" rating for the company in a research report on Monday.January 27, 2025 | marketbeat.comSight Sciences price target lowered to $5 from $5.50 at UBSJanuary 26, 2025 | msn.comSight Sciences, Inc. (NASDAQ:SGHT) Given Average Recommendation of "Hold" by BrokeragesShares of Sight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) have received a consensus rating of "Hold" from the six brokerages that are presently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and one has assigned a buy recoJanuary 25, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) CTO Sells $15,075.94 in StockJanuary 23, 2025 | insidertrades.comSight sciences CTO David Badawi sells $15,081 in stockJanuary 22, 2025 | msn.comSight Sciences, Inc. (NASDAQ:SGHT) CTO David Badawi Sells 5,423 SharesSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) CTO David Badawi sold 5,423 shares of the firm's stock in a transaction on Friday, January 17th. The stock was sold at an average price of $2.78, for a total transaction of $15,075.94. Following the transaction, the chief technology officer now directly owns 1,744,118 shares in the company, valued at $4,848,648.04. The trade was a 0.31 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.January 22, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Insider Jeremy B. Hayden Sells 6,922 SharesJanuary 22, 2025 | insidertrades.comSight sciences chief legal officer sells shares worth $19,250January 22, 2025 | msn.comSight sciences CEO Paul Badawi sells shares worth $72,570January 22, 2025 | msn.comInsider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells 6,922 Shares of StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) insider Jeremy B. Hayden sold 6,922 shares of the business's stock in a transaction that occurred on Friday, January 17th. The shares were sold at an average price of $2.78, for a total value of $19,243.16. Following the completion of the sale, the insider now owns 145,091 shares of the company's stock, valued at approximately $403,352.98. This trade represents a 4.55 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.January 21, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) CEO Sells $72,471.48 in StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) CEO Paul Badawi sold 24,819 shares of the company's stock in a transaction dated Thursday, January 16th. The shares were sold at an average price of $2.92, for a total transaction of $72,471.48. Following the sale, the chief executive officer now directly owns 5,676,331 shares of the company's stock, valued at $16,574,886.52. The trade was a 0.44 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.January 21, 2025 | marketbeat.comKck Ltd. Invests $15.93 Million in Sight Sciences, Inc. (NASDAQ:SGHT)Kck Ltd. acquired a new stake in shares of Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 4,374,975 shares of the company's stock, valued at approximately $15,925January 19, 2025 | marketbeat.comCiti Remains a Hold on Sight Sciences (SGHT)January 17, 2025 | markets.businessinsider.comSight Sciences price target lowered to $3 from $5 at Lake StreetJanuary 16, 2025 | markets.businessinsider.comExpert Outlook: Sight Sciences Through The Eyes Of 5 AnalystsJanuary 15, 2025 | benzinga.comLake Street Capital Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $3.00Lake Street Capital decreased their target price on Sight Sciences from $5.00 to $3.00 and set a "hold" rating for the company in a research note on Wednesday.January 15, 2025 | marketbeat.comSight Sciences (SGHT) Receives a Hold from NeedhamJanuary 15, 2025 | markets.businessinsider.comStifel Nicolaus Sticks to Their Buy Rating for Sight Sciences (SGHT)January 15, 2025 | markets.businessinsider.comSight Sciences (NASDAQ:SGHT) Earns "Hold" Rating from Needham & Company LLCNeedham & Company LLC reaffirmed a "hold" rating on shares of Sight Sciences in a report on Tuesday.January 14, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) CTO Sells $12,482.54 in StockJanuary 11, 2025 | insidertrades.com Remove Ads Get Sight Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGHT and its competitors with MarketBeat's FREE daily newsletter. Email Address SGHT Media Mentions By Week SGHT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGHT News Sentiment▼0.740.70▲Average Medical News Sentiment SGHT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGHT Articles This Week▼22▲SGHT Articles Average Week Remove Ads Get Sight Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGHT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TMCI News DCTH News CLPT News NPCE News NYXH News SMLR News ZIMV News NNOX News TCMD News LUNG News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGHT) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sight Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sight Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
